Dr Kieran Rooney joins UK panel at Xiota
This article was originally published in Scrip
Dr Kieran Rooney is to join the panel of consultants at Xiota, a UK life science consultancy launched in May 2008. Dr Rooney will be joining the UK team, supporting client companies with licensing and merger and acquisition projects both in the UK and internationally. He has more than 20 years' experience in the pharmaceutical and biotechnology sectors.
You may also be interested in...
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.
Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a settlement with the UK company. The Indian firm has also shelved divestment plans for its API business, at least for now.
Nearly 500 shipments of illegal and unapproved prescription drugs and combination medical devices were seized at US borders thanks to Operation Broadsword.